Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

uniQure Announces Company Participation at Citi Healthcare Conference

uniQure N.V.
Posted on: 24 Aug 17
Live webcast of gene therapy panel discussion on Thursday, September 7 at 11:00 am EDT

LEXINGTON, Mass and AMSTERDAM, the Netherlands, Aug. 24, 2017 (GLOBE NEWSWIRE) --  uniQure N.V.  (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it will participate in a gene therapy panel discussion and host investor meetings during the Citi Healthcare Conference held in Boston from September 5-7, 2017.

Matt Kapusta, chief executive officer of uniQure, will participate on the analyst-moderated panel entitled, "Gene-Therapy Manufacturing and Regulatory - Challenges and Opportunities" on Thursday, September 7, 2017 at 11:00 am EDT.  A live webcast of the panel discussion can be accessed through the link displayed in the  Investor Section  of the uniQure website at . A replay of the webcast will be available within 24 hours following the event, and will remain available for at least two weeks.

About uniQure 
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington's disease and cardiovascular diseases.

uniQure Contacts:

For Investors:

Maria E. Cantor
Direct: 339-970-7536
Mobile:  617-680-9452

Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79

For Media:

Tom Malone
Direct:  339-970-7558
Mobile:  339-223-8541

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: uniQure N.V. via GlobeNewswire

Last updated on: 25/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.